"alt_sample_name"	"unique_patient_ID"	"sample_type"	"histological_type"	"primarysite"	"arrayedsite"	"summarygrade"	"summarystage"	"tumorstage"	"substage"	"grade"	"age_at_initial_pathologic_diagnosis"	"pltx"	"tax"	"neo"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"site_of_tumor_first_recurrence"	"primary_therapy_outcome_success"	"debulking"	"percent_normal_cells"	"percent_stromal_cells"	"percent_tumor_cells"	"batch"	"uncurated_author_metadata"
"GSM368661"	1	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	3	NA	NA	NA	NA	NA	"norecurrence"	1170	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-25"	"title: ovarian cancer: O1///geo_accession: GSM368661///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 4///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 39///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368661/GSM368661.cel.gz///data_row_count: 22283"
"GSM368662"	2	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	1050	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-25"	"title: ovarian cancer: O2///geo_accession: GSM368662///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368662/GSM368662.cel.gz///data_row_count: 22283"
"GSM368663"	3	NA	"tumor"	"other"	"ov"	NA	"high"	"late"	3	"b"	3	NA	NA	NA	NA	NA	"recurrence"	810	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-21"	"title: ovarian cancer: O3///geo_accession: GSM368663///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: transitional cell ca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368663/GSM368663.cel.gz///data_row_count: 22283"
"GSM368664"	4	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	420	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-21"	"title: ovarian cancer: O4///geo_accession: GSM368664///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 14///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368664/GSM368664.cel.gz///data_row_count: 22283"
"GSM368665"	5	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	1380	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-21"	"title: ovarian cancer: O5///geo_accession: GSM368665///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 46///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368665/GSM368665.cel.gz///data_row_count: 22283"
"GSM368666"	6	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"c"	2	NA	NA	NA	NA	NA	"norecurrence"	1110	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O6///geo_accession: GSM368666///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368666/GSM368666.cel.gz///data_row_count: 22283"
"GSM368667"	7	NA	"tumor"	"ser"	"ov"	NA	"high"	"early"	1	"a"	3	NA	NA	NA	NA	NA	"norecurrence"	1080	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-25"	"title: ovarian cancer: O7///geo_accession: GSM368667///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368667/GSM368667.cel.gz///data_row_count: 22283"
"GSM368668"	8	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	360	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-26"	"title: ovarian cancer: O8///geo_accession: GSM368668///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368668/GSM368668.cel.gz///data_row_count: 22283"
"GSM368669"	9	NA	"tumor"	"endo"	"ov"	NA	"low"	"early"	1	"a"	1	NA	NA	NA	NA	NA	"norecurrence"	2100	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-26"	"title: ovarian cancer: O9///geo_accession: GSM368669///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 70///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368669/GSM368669.cel.gz///data_row_count: 22283"
"GSM368670"	10	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	1050	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-25"	"title: ovarian cancer: O10///geo_accession: GSM368670///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368670/GSM368670.cel.gz///data_row_count: 22283"
"GSM368671"	11	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	1620	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-25"	"title: ovarian cancer: O11///geo_accession: GSM368671///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 54///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368671/GSM368671.cel.gz///data_row_count: 22283"
"GSM368672"	12	NA	"tumor"	"endo"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	2040	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-25"	"title: ovarian cancer: O12///geo_accession: GSM368672///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 68///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368672/GSM368672.cel.gz///data_row_count: 22283"
"GSM368673"	13	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	1200	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-25"	"title: ovarian cancer: O13///geo_accession: GSM368673///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368673/GSM368673.cel.gz///data_row_count: 22283"
"GSM368674"	14	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"c"	2	NA	NA	NA	NA	NA	"norecurrence"	540	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-21"	"title: ovarian cancer: O14///geo_accession: GSM368674///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 18///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368674/GSM368674.cel.gz///data_row_count: 22283"
"GSM368675"	15	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	NA	900	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-26"	"title: ovarian cancer: O15///geo_accession: GSM368675///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 30///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368675/GSM368675.cel.gz///data_row_count: 22283"
"GSM368676"	16	NA	"tumor"	"clearcell"	"ov"	NA	"low"	"early"	1	"a"	2	NA	NA	NA	NA	NA	"norecurrence"	1350	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-26"	"title: ovarian cancer: O16///geo_accession: GSM368676///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368676/GSM368676.cel.gz///data_row_count: 22283"
"GSM368677"	17	NA	"tumor"	"ser"	"ov"	NA	"high"	"early"	2	"b"	3	NA	NA	NA	NA	NA	"norecurrence"	1200	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-26"	"title: ovarian cancer: O17///geo_accession: GSM368677///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 2b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368677/GSM368677.cel.gz///data_row_count: 22283"
"GSM368678"	18	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	2010	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-26"	"title: ovarian cancer: O18///geo_accession: GSM368678///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 67///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368678/GSM368678.cel.gz///data_row_count: 22283"
"GSM368679"	19	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	930	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-26"	"title: ovarian cancer: O19///geo_accession: GSM368679///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 31///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368679/GSM368679.cel.gz///data_row_count: 22283"
"GSM368680"	20	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"c"	2	NA	NA	NA	NA	NA	"norecurrence"	1140	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-26"	"title: ovarian cancer: O20///geo_accession: GSM368680///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 38///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368680/GSM368680.cel.gz///data_row_count: 22283"
"GSM368681"	21	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	1290	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O21///geo_accession: GSM368681///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 43///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368681/GSM368681.cel.gz///data_row_count: 22283"
"GSM368682"	22	NA	"tumor"	"ser"	"ov"	NA	"high"	"early"	1	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	870	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O22///geo_accession: GSM368682///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 29///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368682/GSM368682.cel.gz///data_row_count: 22283"
"GSM368683"	23	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	360	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O23///geo_accession: GSM368683///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368683/GSM368683.cel.gz///data_row_count: 22283"
"GSM368684"	24	NA	"tumor"	"clearcell"	"ov"	NA	"high"	"early"	1	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	1530	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O24///geo_accession: GSM368684///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 51///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368684/GSM368684.cel.gz///data_row_count: 22283"
"GSM368685"	25	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	1200	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O25///geo_accession: GSM368685///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368685/GSM368685.cel.gz///data_row_count: 22283"
"GSM368686"	26	NA	"tumor"	"mix"	"ov"	NA	"high"	"early"	1	"a"	3	NA	NA	NA	NA	NA	"norecurrence"	1110	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O26///geo_accession: GSM368686///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1a///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr, clear cell ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368686/GSM368686.cel.gz///data_row_count: 22283"
"GSM368687"	27	NA	"tumor"	"endo"	"ov"	NA	"high"	"early"	1	"b"	3	NA	NA	NA	NA	NA	"norecurrence"	1470	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O27///geo_accession: GSM368687///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368687/GSM368687.cel.gz///data_row_count: 22283"
"GSM368688"	28	NA	"tumor"	"endo"	"ov"	NA	"high"	"early"	1	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	1080	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O28///geo_accession: GSM368688///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 1c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368688/GSM368688.cel.gz///data_row_count: 22283"
"GSM368689"	29	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	NA	1470	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-01-28"	"title: ovarian cancer: O29///geo_accession: GSM368689///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368689/GSM368689.cel.gz///data_row_count: 22283"
"GSM368690"	30	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"c"	2	NA	NA	NA	NA	NA	NA	1380	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-03-02"	"title: ovarian cancer: O30///geo_accession: GSM368690///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 46///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368690/GSM368690.cel.gz///data_row_count: 22283"
"GSM368691"	31	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	600	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-03-02"	"title: ovarian cancer: O31///geo_accession: GSM368691///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368691/GSM368691.cel.gz///data_row_count: 22283"
"GSM368692"	32	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	1110	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-03-02"	"title: ovarian cancer: O32///geo_accession: GSM368692///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368692/GSM368692.cel.gz///data_row_count: 22283"
"GSM368693"	33	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"b"	2	NA	NA	NA	NA	NA	"norecurrence"	1110	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-03-02"	"title: ovarian cancer: O33///geo_accession: GSM368693///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 37///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368693/GSM368693.cel.gz///data_row_count: 22283"
"GSM368694"	34	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	3	NA	NA	NA	NA	NA	"norecurrence"	1200	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-03-02"	"title: ovarian cancer: O34///geo_accession: GSM368694///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 40///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368694/GSM368694.cel.gz///data_row_count: 22283"
"GSM368695"	35	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	1410	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2005-03-02"	"title: ovarian cancer: O35///geo_accession: GSM368695///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 47///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368695/GSM368695.cel.gz///data_row_count: 22283"
"GSM368696"	36	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"b"	2	NA	NA	NA	NA	NA	"recurrence"	1260	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-09-30"	"title: ovarian cancer: O36///geo_accession: GSM368696///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3b///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 42///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368696/GSM368696.cel.gz///data_row_count: 22283"
"GSM368697"	37	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"c"	2	NA	NA	NA	NA	NA	"norecurrence"	1560	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-09-30"	"title: ovarian cancer: O37///geo_accession: GSM368697///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 52///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368697/GSM368697.cel.gz///data_row_count: 22283"
"GSM368698"	38	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	NA	660	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-10-01"	"title: ovarian cancer: O38///geo_accession: GSM368698///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: NA///characteristics_ch1.5: overall survival time: 22///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368698/GSM368698.cel.gz///data_row_count: 22283"
"GSM368699"	39	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	1350	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-10-01"	"title: ovarian cancer: O39///geo_accession: GSM368699///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368699/GSM368699.cel.gz///data_row_count: 22283"
"GSM368700"	40	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"recurrence"	600	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-10-01"	"title: ovarian cancer: O40///geo_accession: GSM368700///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368700/GSM368700.cel.gz///data_row_count: 22283"
"GSM368701"	41	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"c"	2	NA	NA	NA	NA	NA	"norecurrence"	1350	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-10-01"	"title: ovarian cancer: O41///geo_accession: GSM368701///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 45///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368701/GSM368701.cel.gz///data_row_count: 22283"
"GSM368702"	42	NA	"tumor"	"endo"	"ov"	NA	"high"	"late"	4	NA	3	NA	NA	NA	NA	NA	"norecurrence"	960	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-10-01"	"title: ovarian cancer: O42///geo_accession: GSM368702///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 4///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 32///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368702/GSM368702.cel.gz///data_row_count: 22283"
"GSM368703"	43	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	3	NA	NA	NA	NA	NA	"norecurrence"	1470	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-10-01"	"title: ovarian cancer: O43///geo_accession: GSM368703///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 49///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368703/GSM368703.cel.gz///data_row_count: 22283"
"GSM368704"	44	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	"c"	2	NA	NA	NA	NA	NA	"recurrence"	450	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2004-09-29"	"title: ovarian cancer: O44///geo_accession: GSM368704///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3c///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 15///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368704/GSM368704.cel.gz///data_row_count: 22283"
"GSM368705"	45	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"recurrence"	1290	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O45///geo_accession: GSM368705///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 43///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368705/GSM368705.cel.gz///data_row_count: 22283"
"GSM368706"	46	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	1	NA	NA	NA	NA	NA	"norecurrence"	2190	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-26"	"title: ovarian cancer: O46///geo_accession: GSM368706///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 73///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368706/GSM368706.cel.gz///data_row_count: 22283"
"GSM368707"	47	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	1590	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-21"	"title: ovarian cancer: O47///geo_accession: GSM368707///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 53///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368707/GSM368707.cel.gz///data_row_count: 22283"
"GSM368708"	48	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	1	NA	NA	NA	NA	NA	"recurrence"	1140	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-27"	"title: ovarian cancer: O48///geo_accession: GSM368708///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: I///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 38///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368708/GSM368708.cel.gz///data_row_count: 22283"
"GSM368709"	49	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	1530	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-27"	"title: ovarian cancer: O49///geo_accession: GSM368709///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 51///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368709/GSM368709.cel.gz///data_row_count: 22283"
"GSM368710"	50	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	1650	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O50///geo_accession: GSM368710///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 55///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368710/GSM368710.cel.gz///data_row_count: 22283"
"GSM368711"	51	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	810	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-27"	"title: ovarian cancer: O51///geo_accession: GSM368711///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368711/GSM368711.cel.gz///data_row_count: 22283"
"GSM368712"	52	NA	"tumor"	"endo"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	210	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-27"	"title: ovarian cancer: O52///geo_accession: GSM368712///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: endometr ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 7///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368712/GSM368712.cel.gz///data_row_count: 22283"
"GSM368713"	53	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	1320	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-18"	"title: ovarian cancer: O53///geo_accession: GSM368713///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 44///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368713/GSM368713.cel.gz///data_row_count: 22283"
"GSM368714"	54	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	660	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O54///geo_accession: GSM368714///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 22///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368714/GSM368714.cel.gz///data_row_count: 22283"
"GSM368715"	55	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	1080	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O55///geo_accession: GSM368715///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 36///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368715/GSM368715.cel.gz///data_row_count: 22283"
"GSM368716"	56	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	1050	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-21"	"title: ovarian cancer: O56///geo_accession: GSM368716///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 35///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368716/GSM368716.cel.gz///data_row_count: 22283"
"GSM368717"	57	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	1020	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-27"	"title: ovarian cancer: O57///geo_accession: GSM368717///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 34///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368717/GSM368717.cel.gz///data_row_count: 22283"
"GSM368718"	58	NA	"tumor"	"other"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	1020	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-27"	"title: ovarian cancer: O58///geo_accession: GSM368718///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: sarcomatoid///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 34///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368718/GSM368718.cel.gz///data_row_count: 22283"
"GSM368719"	59	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	690	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-28"	"title: ovarian cancer: O59///geo_accession: GSM368719///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368719/GSM368719.cel.gz///data_row_count: 22283"
"GSM368720"	60	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	720	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-28"	"title: ovarian cancer: O60///geo_accession: GSM368720///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 24///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368720/GSM368720.cel.gz///data_row_count: 22283"
"GSM368721"	61	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	750	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-28"	"title: ovarian cancer: O61///geo_accession: GSM368721///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368721/GSM368721.cel.gz///data_row_count: 22283"
"GSM368722"	62	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	750	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-28"	"title: ovarian cancer: O62///geo_accession: GSM368722///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368722/GSM368722.cel.gz///data_row_count: 22283"
"GSM368723"	63	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	630	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O63///geo_accession: GSM368723///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 21///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368723/GSM368723.cel.gz///data_row_count: 22283"
"GSM368724"	64	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	360	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O64///geo_accession: GSM368724///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 12///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368724/GSM368724.cel.gz///data_row_count: 22283"
"GSM368725"	65	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	390	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O65///geo_accession: GSM368725///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 13///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368725/GSM368725.cel.gz///data_row_count: 22283"
"GSM368726"	66	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	210	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O66///geo_accession: GSM368726///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 7///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368726/GSM368726.cel.gz///data_row_count: 22283"
"GSM368727"	67	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	300	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O67///geo_accession: GSM368727///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 10///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368727/GSM368727.cel.gz///data_row_count: 22283"
"GSM368728"	68	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	600	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-18"	"title: ovarian cancer: O68///geo_accession: GSM368728///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368728/GSM368728.cel.gz///data_row_count: 22283"
"GSM368729"	69	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	1740	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-18"	"title: ovarian cancer: O69///geo_accession: GSM368729///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 58///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368729/GSM368729.cel.gz///data_row_count: 22283"
"GSM368730"	70	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"recurrence"	390	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-19"	"title: ovarian cancer: O70///geo_accession: GSM368730///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 13///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368730/GSM368730.cel.gz///data_row_count: 22283"
"GSM368731"	71	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	240	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-19"	"title: ovarian cancer: O71///geo_accession: GSM368731///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 8///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368731/GSM368731.cel.gz///data_row_count: 22283"
"GSM368732"	72	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	450	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-19"	"title: ovarian cancer: O72///geo_accession: GSM368732///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 15///characteristics_ch1.6: overall survival event: 1///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368732/GSM368732.cel.gz///data_row_count: 22283"
"GSM368733"	73	NA	"tumor"	"undifferentiated"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	810	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-21"	"title: ovarian cancer: O73///geo_accession: GSM368733///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: undifferentiated ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 27///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368733/GSM368733.cel.gz///data_row_count: 22283"
"GSM368734"	74	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	690	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-19"	"title: ovarian cancer: O74///geo_accession: GSM368734///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368734/GSM368734.cel.gz///data_row_count: 22283"
"GSM368735"	75	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	870	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-26"	"title: ovarian cancer: O75///geo_accession: GSM368735///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 29///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368735/GSM368735.cel.gz///data_row_count: 22283"
"GSM368736"	76	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"norecurrence"	750	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-26"	"title: ovarian cancer: O76///geo_accession: GSM368736///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 25///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368736/GSM368736.cel.gz///data_row_count: 22283"
"GSM368737"	77	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	NA	3	NA	NA	NA	NA	NA	"recurrence"	600	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-07-26"	"title: ovarian cancer: O77///geo_accession: GSM368737///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: III///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 20///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368737/GSM368737.cel.gz///data_row_count: 22283"
"GSM368738"	78	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"recurrence"	690	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-21"	"title: ovarian cancer: O78///geo_accession: GSM368738///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 23///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368738/GSM368738.cel.gz///data_row_count: 22283"
"GSM368739"	79	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"norecurrence"	720	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-21"	"title: ovarian cancer: O79///geo_accession: GSM368739///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 0///characteristics_ch1.5: overall survival time: 24///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368739/GSM368739.cel.gz///data_row_count: 22283"
"GSM368740"	80	NA	"tumor"	"ser"	"ov"	NA	"low"	"late"	3	NA	2	NA	NA	NA	NA	NA	"recurrence"	630	"living"	NA	NA	NA	NA	NA	NA	NA	NA	"2006-08-11"	"title: ovarian cancer: O80///geo_accession: GSM368740///status: Public on Feb 09 2009///submission_date: Feb 09 2009///last_update_date: Aug 24 2010///type: RNA///channel_count: 1///source_name_ch1: ovarian cancer///organism_ch1: Homo sapiens///characteristics_ch1: tissue: frozen tumor///characteristics_ch1.1: figo stage: 3///characteristics_ch1.2: grade: II///characteristics_ch1.3: histological type: serous ovca///characteristics_ch1.4: residual tumor: 1///characteristics_ch1.5: overall survival time: 21///characteristics_ch1.6: overall survival event: 0///molecule_ch1: total RNA///extract_protocol_ch1: Total cellular RNA was isolated from tumor tissue, using the Qiagen Rneasy Mini Kit.///label_ch1: biotin///label_protocol_ch1: cDNA was synthesised from 5 g total RNA by reverse transcription, synthesis of biotin-labeled cRNA was performed using the BioArray High Yield RNA Transcription kit.///taxid_ch1: 9606///hyb_protocol: The fragmented cRNA was hybridised to HGU133 arrays at 45 C in a hybridization oven for 16 hr.///scan_protocol: Chip scanning was done with an Affymetrix Gene Array Scanner G2500A.///description: frozen tissue sample///data_processing: Signals and detection calls were calculated with the R package affy according to the standard MAS 5.0 protocol of the chip manufacturer.///platform_id: GPL96///contact_name: Jan,,Budczies///contact_email: jan.budczies@charite.de///contact_department: Institute of Pathology///contact_institute: Charite - Universitaetsmedizin Berlin///contact_address: Chariteplatz 2///contact_city: Berlin///contact_zip.postal_code: 10117///contact_country: Germany///contact_web_link: http://www.charite.de/ch/patho///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM368nnn/GSM368740/GSM368740.cel.gz///data_row_count: 22283"
